Here's a thought...Maybe the company should set aside $ 1m of their $ 11M spare change...
Buy back 5 million shares at say . 20 to .25
Exhaust the "anonymous mystery tax loss seller"
Launch a "real" concerted US & Cdn IR /promo/marketing campaign.
Get the share price up to .50 to .75 range
Do a PP (if necessary) to replenish the coffers (although maybe not even required, if they found a SAMI Dist. partner, or a Dialco 10% eauity partner, or Baxter coughs up on Tranche 2, before Interim given open Label access to the "exceeding expectation" Tigris reults - at say 40 patients?, 50? 75?.
A lot less net dilution. More palatable SP. Happier shareholders.
It's a win win !
MM